AI Cognitive Health & Brain Training for Seniors
Platform combining clinically-validated brain training games with cognitive health tracking — monitoring memory, attention, and processing speed over time, alerting families to concerning decline patterns, and suggesting interventions.
Problem Solved
6.7M Americans have Alzheimer's. Cognitive decline starts 10-15 years before diagnosis. Early detection delays progression by 3-5 years. Brain games without clinical validation waste time. Families notice decline too late for effective intervention.
Target Audience
Adults 55+, family members of seniors at risk, neurologists, memory care facilities
Revenue Model
$14.99/month individual. $24.99/month family plan with monitoring. Revenue target: $200K-$1.5M ARR by year 2.
Key Features to Build
- Clinically-validated cognitive exercises
- Longitudinal cognitive tracking dashboard
- AI decline pattern detection and alerts
- Family member monitoring access
- Personalized brain health recommendations
Known Competitors
Why Now — Market Timing
Alzheimer's costs $345B annually. AI can detect cognitive decline patterns years earlier. Lecanemab (Leqembi) approval makes early detection actionable. Aging population creating massive demand. Digital therapeutics gaining FDA recognition.
Validate This Idea with AI
Get a detailed viability report with market analysis, competition assessment, and financial projections — in minutes.
Validate "AI Cognitive Health & Brain Training for Seniors"